Comparisons between different anti-osteoporosis medications on postfracture mortality: A population-based study
CONCLUSION: This real-world mega data study suggests that the usage of osteoporotic medication, especially the long-acting regimen, may lower postfracture mortality.PMID:36317591 | DOI:10.1210/clinem/dgac636
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Chih-Hsing Wu Chia-Chun Li Yu-Hsuan Hsu Fu-Wen Liang Yin-Fan Chang Jawl-Shan Hwang Source Type: research
More News: Actonel | Chia | Databases & Libraries | Endocrinology | Epidemics | Epidemiology | Evista | Health Insurance | Insurance | Orthopaedics | Osteoporosis | Reclast | Risedronate | Study | Taiwan Health | Xgeva | Zometa